A comparative in vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 3008-3011

  Hoban, D J ^a   Bouchillon, S K ^a   Karlowsky, J A ^a   Johnson, J L ^a   Butler, D L ^a   Miller, L A ^a   Poupard, J A ^a  

^a Division of Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; COTRIMOXAZOLE; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN G; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; EUROPE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORTH AMERICA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SOUTH AMERICA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; EUROPE; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NAPHTHYRIDINES; NORTH AMERICA; OFLOXACIN; SOUTH AMERICA; STREPTOCOCCUS PNEUMONIAE;

EID: 0033751574     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.3008-3011.2000     Document Type: Article

References (17)

1. Antimicrobial resistance in Streptococcus pneumoniae
2. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993
3. Community acquired pneumonia in adults: Guidelines for management
4. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
5. Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone
6. Antipneumococcal activities of gemifloxacin compared to those of nine other agents
7. Clonal relationships among high level penicillin resistant Streptococcus pneumoniae in the United States
8. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
9. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms
10. International multicenter investigation of LB20304, a new fluoronaphthyridone
11. Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines
12. Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone
13. In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone
14. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone
15. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: Results of a Canadian national surveillance study